Opportunity Information: Apply for PA 16 188
Apply for PA 16 188
- The HHS-NIH11 in the education, food and nutrition, health sector is offering a public funding opportunity titled "Mechanisms, Models, Measurement, and Management in Pain Research (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.213, 93.279, 93.307, 93.361, 93.846, 93.847, 93.853, 93.866,.
- This funding opportunity was created on Apr 14, 2016 and posted on Apr 14, 2016.
- Applicants must submit their applications by May 07, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity titled "Mechanisms, Models, Measurement, and Management in Pain Research (R01)" (Funding Opportunity Number PA-16-188) is an investigator-initiated grant program designed to expand and deepen the national pain research portfolio across basic, clinical, and translational science. The FOA is framed as a broad call to the scientific community, highlighting that multiple NIH Institutes and Centers have aligned interests in pain research and want to encourage studies that match their individual missions. In practice, this means the announcement is meant to stimulate a wide range of projects rather than narrowing applicants to a single disease area, organ system, or methodological approach. The central theme is that pain remains a complex, highly individualized experience, and despite progress in understanding parts of the nervous system involved in pain signaling, major gaps persist in explaining why pain varies so much across individuals and why treatment remains difficult for many patients.
A key priority emphasized in the description is the need for new advances spanning the full spectrum of science, from "micro" level investigations (molecular, cellular, genetic, and neural circuit mechanisms) to "macro" level perspectives (behavioral, psychological, social, and population-level factors). The FOA underscores that pain is not just a neurobiological phenomenon but also a lived experience shaped by context, behavior, and environment. As a result, the opportunity implicitly invites proposals that integrate multiple levels of analysis, such as linking molecular pathways to neural system function, patient-reported outcomes, clinical trajectories, and social determinants of health. This wide scope is consistent with the title, which points to four broad domains: mechanisms (how pain is generated and maintained), models (experimental and clinical models that capture relevant features of pain), measurement (tools and approaches to assess pain and related outcomes), and management (strategies to prevent, treat, and mitigate pain and its impacts).
Another major scientific motivation highlighted is the unresolved problem of pain chronicity, especially the transition from acute pain after an injury or insult to a chronic pain state. The FOA explicitly notes that understanding how and why some individuals develop chronic pain while others recover remains limited. This signals strong interest in studies that investigate risk and protective factors, biological and psychosocial mechanisms of chronification, predictive markers, and intervention points that could prevent long-term disability. Projects might reasonably address trajectories of recovery, susceptibility factors, and mechanisms that sustain pain over time, including changes in the nervous system, immune contributions, endocrine or stress-related pathways, behavioral adaptations, and social influences that can amplify or prolong symptoms.
The announcement strongly encourages interdisciplinary and multidisciplinary research teams, reflecting an expectation that the most meaningful advances in pain research often require collaboration across fields such as neuroscience, immunology, psychology, rehabilitation science, anesthesiology, primary care, psychiatry, epidemiology, biostatistics, engineering, and digital health. This emphasis suggests the FOA is receptive to studies that combine complementary methods, for example mechanistic laboratory work coupled with clinical phenotyping, neuroimaging paired with behavioral assays, or computational modeling integrated with longitudinal patient data. The underlying message is that pain is too multifaceted to be solved by single-discipline approaches alone, and that team science is viewed as a strength.
The FOA also explicitly encourages participation by investigators from underrepresented groups, including underrepresented minority, disabled, and women investigators. While the description does not lay out special set-asides in the provided text, the language signals NIH intent to broaden who leads and shapes the pain research agenda, and it aligns with the general NIH interest in fostering a diverse research workforce. Applicants who are early-stage or from historically underrepresented backgrounds would typically interpret this as supportive language indicating that their participation is welcomed and valued.
From an administrative standpoint, this is a discretionary grant opportunity using the NIH R01 mechanism, which generally supports mature, hypothesis-driven or well-justified research programs with substantial scope. The sponsoring agency is the U.S. Department of Health and Human Services, National Institutes of Health (listed as HHS-NIH11). The opportunity was posted on April 14, 2016, with a closing date of May 7, 2019 (both original and current closing dates shown as the same in the source data). The Funding Activity Category is listed as Education, Food and Nutrition, Health, and the CFDA program numbers associated with participating NIH components include 93.121, 93.213, 93.279, 93.307, 93.361, 93.846, 93.847, 93.853, and 93.866, reflecting the involvement of multiple NIH Institutes and Centers.
Eligibility is broad and includes many types of organizations commonly allowed to apply for NIH research funding. Eligible applicants listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with and without 501(c)(3) status (excluding higher education institutions where noted); for-profit organizations other than small businesses; small businesses; and other entities as clarified in additional eligibility text. This breadth suggests the NIH intended to attract proposals from traditional academic research environments as well as hospitals, research institutes, community-based organizations with appropriate capacity, and private-sector groups capable of conducting rigorous pain research.
In overall terms, PA-16-188 is best understood as a wide umbrella solicitation meant to energize pain research across the NIH, with particular focus on improving understanding of pain mechanisms, building and refining models that better reflect human pain conditions, strengthening the way pain is measured and characterized, and advancing prevention and management strategies. The FOA communicates that even with advances in mapping pain pathways, pain remains deeply personal and variable, and that solving chronic pain and improving treatment outcomes will require integrated, cross-disciplinary work that spans biology, behavior, and social context.
Frequently Asked Questions (FAQ) - NIH PA-16-188: Mechanisms, Models, Measurement, and Management in Pain Research (R01)
What is the funding opportunity called?
The funding opportunity is titled "Mechanisms, Models, Measurement, and Management in Pain Research (R01)".
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PA-16-188.
What type of grant mechanism is used?
This opportunity uses the NIH R01 mechanism, which generally supports substantial, investigator-initiated research projects.
Who is the sponsoring agency?
The sponsoring agency is the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), listed as HHS-NIH11.
Is this opportunity investigator-initiated or a targeted topic solicitation?
It is described as an investigator-initiated grant program and is framed as a broad call intended to stimulate a wide range of pain research projects, rather than limiting applicants to one disease area, organ system, or single methodological approach.
What is the main purpose of this FOA?
The stated purpose is to expand and deepen the national pain research portfolio across basic, clinical, and translational science, addressing persistent gaps in understanding why pain varies across individuals and why treatments remain difficult for many patients.
What are the major scientific domains emphasized by the FOA?
The FOA highlights four broad domains reflected in the title:
- Mechanisms: how pain is generated, processed, and maintained
- Models: experimental and clinical models that capture meaningful features of pain
- Measurement: tools and approaches to assess pain and related outcomes
- Management: strategies to prevent, treat, and reduce the impact of pain
What kinds of pain research are encouraged (basic, clinical, translational)?
The opportunity explicitly supports research spanning basic, clinical, and translational science, with encouragement for studies that connect discoveries across these stages (for example, linking biological mechanisms to clinical outcomes).
Does the FOA encourage research at different levels of analysis?
Yes. A major emphasis is advancing pain science across both:
- "Micro" levels (molecular, cellular, genetic, and neural circuit mechanisms)
- "Macro" levels (behavioral, psychological, social, and population-level factors)
The FOA frames pain as both a neurobiological process and a lived experience shaped by context and environment.
Is interdisciplinary or multidisciplinary research encouraged?
Yes. The FOA strongly encourages interdisciplinary and multidisciplinary teams, reflecting the view that progress in pain research often requires collaboration across multiple scientific and clinical fields.
What disciplines does the FOA suggest may be relevant to competitive projects?
The FOA references collaboration across areas such as neuroscience, immunology, psychology, rehabilitation science, anesthesiology, primary care, psychiatry, epidemiology, biostatistics, engineering, and digital health.
Does the FOA favor a single disease area or organ system?
No. The opportunity is described as a broad umbrella solicitation and is not framed around a single disease, organ system, or narrow topic area.
What problem in pain research is highlighted as especially unresolved?
The FOA highlights the unresolved challenge of pain chronicity, especially the transition from acute pain to chronic pain, and notes that understanding why some individuals recover while others develop chronic pain remains limited.
Are projects about preventing chronic pain relevant?
Yes. The FOA signals strong interest in understanding chronification and identifying risk and protective factors, predictive markers, and intervention points that could help prevent long-term disability and persistent pain.
What kinds of factors related to chronic pain does the FOA indicate may be studied?
Based on the description, relevant factors may include biological and psychosocial mechanisms that contribute to chronification, including potential roles for nervous system changes, immune contributions, endocrine or stress-related pathways, behavioral adaptations, and social influences that can amplify or prolong symptoms.
Does the FOA encourage research that integrates multiple types of data or methods?
Yes. The description suggests receptiveness to integrated approaches, such as combining mechanistic laboratory work with clinical phenotyping, pairing neuroimaging with behavioral assays, or integrating computational modeling with longitudinal patient data.
Are studies about pain measurement and assessment within scope?
Yes. One of the four named domains is Measurement, indicating support for improved tools and approaches to assess pain and related outcomes, including approaches that may connect patient-reported outcomes with clinical trajectories and other determinants.
Are studies about pain management within scope?
Yes. Management is a core domain of the FOA, and the opportunity includes advancing strategies to prevent, treat, and mitigate pain and its impacts.
How does the FOA describe pain as an experience?
The FOA emphasizes that pain is complex and highly individualized and shaped not only by nervous system signaling but also by context, behavior, environment, and social factors.
Are applications from underrepresented investigators encouraged?
Yes. The FOA explicitly encourages participation by underrepresented minority, disabled, and women investigators, signaling NIH interest in broadening who leads and shapes the pain research agenda.
Does the FOA indicate involvement from multiple NIH Institutes and Centers?
Yes. The FOA is described as aligned with the interests of multiple NIH Institutes and Centers, encouraging studies that match their individual missions and contributing to a broad national portfolio in pain research.
What is the Funding Activity Category listed for this opportunity?
The Funding Activity Category is listed as Education, Food and Nutrition, Health.
When was this opportunity posted?
The opportunity was posted on April 14, 2016.
What is the closing date listed for this opportunity?
The closing date is listed as May 7, 2019 (the source data shows the original and current closing dates as the same).
Which CFDA program numbers are associated with the participating NIH components?
The description lists the following CFDA program numbers: 93.121, 93.213, 93.279, 93.307, 93.361, 93.846, 93.847, 93.853, and 93.866.
Who is eligible to apply?
Eligibility is broad and includes a wide range of organization types commonly allowed to apply for NIH research funding, including:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Other Native American tribal organizations
- Public housing authorities / Indian housing authorities
- Nonprofits with 501(c)(3) status (other than institutions of higher education, where noted)
- Nonprofits without 501(c)(3) status (other than institutions of higher education, where noted)
- For-profit organizations (other than small businesses)
- Small businesses
- Other entities as clarified in additional eligibility text
Does the FOA appear limited to academic institutions only?
No. The eligibility list includes academic institutions, government entities, nonprofits, tribal organizations, public housing authorities, and for-profit organizations, indicating the FOA is open to many organizational types with the capacity to conduct rigorous pain research.
What is the overall takeaway for applicants considering PA-16-188?
PA-16-188 is best understood as a broad NIH-wide call to energize pain research across mechanisms, models, measurement, and management, with notable emphasis on the individualized nature of pain, the challenge of chronic pain development, and the value of integrated, team-based science spanning biology, behavior, and social context.
Browse more opportunities from the same category: Education, Food and Nutrition, Health
Next opportunity: Paul Calabresi Career Development Award for Clinical Oncology (K12)
Previous opportunity: ROSES 2016: Heliophysics Technology and Instrument Development for Science
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 16 188
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 16 188) also looked into and applied for these:
| Funding Opportunity |
|---|
| Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01) Apply for PA 16 332 Funding Number: PA 16 332 Agency: HHS-NIH11 Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| State and Territory Produce Safety Implementation Program Expansion for Entrance into Competition B of PAR-16-137 (U18) Apply for PAR 19 017 Funding Number: PAR 19 017 Agency: Department of Health and Human Services, Food and Drug Administration Category: Education, Food and Nutrition, Health Funding Amount: $775,000 |
| HEAL Initiative: Early Phase Pain Investigation Clinical Network - Clinical Coordinating Center (U24 Clinical Trial Not Allowed Apply for RFA NS 19 023 Funding Number: RFA NS 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| HEAL Initiative: Early Phase Pain Investigation Clinical Network - Specialized Clinical Centers (U24 Clinical Trial Not Allowed) Apply for RFA NS 19 025 Funding Number: RFA NS 19 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $150,000 |
| HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for RFA NS 19 021 Funding Number: RFA NS 19 021 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Health Promotion Among Racial and Ethnic Minority Males (R01) Apply for PA 16 428 Funding Number: PA 16 428 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01) Apply for PAR 17 093 Funding Number: PAR 17 093 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) Apply for PA 18 034 Funding Number: PA 18 034 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Optional) Apply for PA 18 010 Funding Number: PA 18 010 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) Apply for PAR 18 009 Funding Number: PAR 18 009 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Apply for PA 18 141 Funding Number: PA 18 141 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Health Promotion Among Racial and Ethnic Minority Males (R01 Clinical Trial Optional) Apply for PA 18 144 Funding Number: PA 18 144 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Apply for PAR 18 530 Funding Number: PAR 18 530 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) Apply for PA 18 713 Funding Number: PA 18 713 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional) Apply for PAR 18 727 Funding Number: PAR 18 727 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Apply for PA 18 856 Funding Number: PA 18 856 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Apply for PAR 18 857 Funding Number: PAR 18 857 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $200,000 |
| Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) Apply for PA 18 935 Funding Number: PA 18 935 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| HEAL Initiative: Early Phase Pain Investigation Clinical Network - Data Coordinating Center (U24 Clinical Trials Not Allowed) Apply for RFA NS 19 024 Funding Number: RFA NS 19 024 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed) Apply for RFA CA 19 044 Funding Number: RFA CA 19 044 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $375,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 16 188", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
